https://www.tandfonline.com/journals/ttrb20
Journal metrics 日记帐指标
https://www.tandfonline.com/action/journalInformation?show=journalMetrics&journalCode=ttrb20
Usage 用法
- 58K annual downloads/views
58K 年下载量/浏览量
Citation metrics 引文指标
- 2.8 (2022) Impact Factor 2.8 (2022) 影响因子
- 3.0 (2022) 5 year IF
3.0 (2022) 5 年 IF - 6.6 (2022) CiteScore (Scopus)
6.6 (2022) 引用评分 (Scopus) - Q1 CiteScore Best Quartile
Q1 CiteScore 最佳四分位数 - 1.127 (2022) SNIP 1.127 (2022) 狙击
- 0.892 (2022) SJR 0.892 (2022) SJR
Speed/acceptance 速度/验收
- 41 days avg. from submission to first decision
从提交到第一次决定的平均时间为 41 天 - 68 days avg. from submission to first post-review decision
从提交到第一次审查后决定平均 68 天 - 13 days avg. from acceptance to online publication
从接受到在线发布的平均时间为 13 天 - 18% acceptance rate
- 18% 录取率
Journal information 期刊信息
打印 ISSN: 2168-0566 在线ISSN: 2168-0582
4 issues per year 每年 4 期
Transportmetrica B: Transport Dynamics is indexed in Science Citation Index Expanded; Scopus; Social Scisearch; Current Contents®/Social and Behavioral Sciences; Current Contents®/Engineering, Computing, and Technology; Transportation Research Information Services, and Emcare/Mosby's Index.
Transportmetrica B: Transport Dynamics在Science Citation Index Expanded中被索引;黄芪;社会科学研究;当前内容®/社会和行为科学;当前内容®/工程、计算和技术;交通研究信息服务和 Emcare/Mosby 指数。
香港运输学会有限公司及本所出版社Taylor & Francis竭力确保我们刊物所载所有资料(「内容」)准确无误。然而,香港交通学会有限公司和我们的出版商Taylor & Francis、我们的代理人(包括编辑、编辑团队或编辑委员会的任何成员,以及任何客座编辑)和我们的许可人对内容的准确性、完整性或适合任何目的不作任何陈述或保证。本刊物所表达的任何意见和观点均为作者的意见和观点,并非香港运输学会有限公司和我们的出版商Taylor & Francis的观点或认可。不应依赖内容的准确性,而应通过主要信息来源进行独立验证。香港运输学会有限公司及本刊物Taylor & Francis概不负责因使用内容而直接或间接引致的任何损失、诉讼、申索、法律程序、要求、成本、开支、损害赔偿及其他责任。访问和使用条款和条件可在 http://www.tandfonline.com/page/terms-and-conditions 找到。
Publication history 出版历史
Associated with:
与以下相关人员:
- Transportmetrica A: Transport Science (2013 - current)
Transportmetrica A:运输科学(2013 年至今)
Aims and scope 目标和范围
https://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=ttrb20
Transportmetrica B is an international journal that aims to bring together contributions of advanced research in understanding and practical experience in handling the dynamic aspects of transport systems and behavior, and hence the sub-title is set as “Transport Dynamics”.
Transportmetrica B 是一本国际期刊,旨在汇集在处理运输系统和行为的动态方面的理解和实践经验的高级研究贡献,因此副标题设置为“运输动力学”。
Transport dynamics can be considered from various scales and scopes ranging from dynamics in traffic flow, travel behavior (e.g. learning process), logistics, transport policy, to traffic control. Thus, the journal welcomes research papers that address transport dynamics from a broad perspective, ranging from theoretical studies to empirical analysis of transport systems or behavior based on actual data.
交通动态可以从各种规模和范围来考虑,从交通流动态、出行行为(例如学习过程)、物流、交通政策到交通控制。因此,该杂志欢迎从广泛角度探讨交通动力学的研究论文,从理论研究到基于实际数据的交通系统或行为的实证分析。
The scope of Transportmetrica B includes, but is not limited to, the following: dynamic traffic assignment, dynamic transit assignment, dynamic activity-based modeling, applications of system dynamics in transport planning, logistics planning and optimization, traffic flow analysis, dynamic programming in transport modeling and optimization, traffic control, land-use and transport dynamics, day-to-day learning process (model and behavioral studies), time-series analysis of transport data and demand, traffic emission modeling, time-dependent transport policy analysis, transportation network reliability and vulnerability, simulation of traffic system and travel behavior, longitudinal analysis of traveler behavior, etc.
Transportmetrica B 的范围包括但不限于以下内容:动态交通分配、动态交通分配、基于动态活动的建模、系统动力学在交通规划中的应用、物流规划和优化、交通流分析、交通建模和优化中的动态规划、交通控制、土地利用和交通动态、日常学习过程(模型和行为研究), 交通数据与需求时间序列分析、交通排放建模、瞬态交通政策分析、交通网络可靠性与脆弱性、交通系统与出行行为模拟、出行者行为纵向分析等。
All manuscript submissions are subject to initial appraisal by the Editor, and, if found suitable for further consideration, to peer review by independent, anonymous expert referees.
所有提交的稿件均需经过编辑的初步评估,如果认为适合进一步考虑,则由独立的匿名专家审稿人进行同行评审。
Peer Review Policy 同行评议政策
All peer review is single anonymized and submission is online via ScholarOne Manuscripts.
所有同行评审都是匿名的,通过ScholarOne Manuscripts在线提交。
STAR 星
Taylor & Francis/Routledge are committed to the widest possible dissemination of its journals to non-profit institutions in developing countries. Our STAR initiative offers individual researchers in Africa, South Asia and many parts of South East Asia the opportunity to gain one month’s free online access to 1,300 Taylor & Francis journals. For more information, please visit the STAR website.
Taylor & Francis/Routledge致力于向发展中国家的非营利机构尽可能广泛地传播其期刊。我们的STAR计划为非洲、南亚和东南亚许多地区的个体研究人员提供了一个月免费在线访问1,300种Taylor&Francis期刊的机会。欲了解更多信息,请访问STAR网站。
Authors can choose to publish gold open access in this journal.
作者可以选择在本期刊上发表黄金开放获取。
Read the Instructions for Authors for information on how to submit your article.
阅读作者须知,了解如何提交文章。
Instructions for authors
作者须知
感谢您选择向我们提交您的论文。这些说明将确保我们拥有所需的一切,以便您的论文能够顺利通过同行评审、生产和出版。请花时间阅读并尽可能密切关注它们,因为这样做将确保您的论文符合期刊的要求。
For general guidance on every stage of the publication process, please visit our Author Services website.
有关出版过程每个阶段的一般指导,请访问我们的作者服务网站。
For editing support, including translation and language polishing, explore our Editing Services website
如需编辑支持,包括翻译和语言润色,请访问我们的编辑服务网站
This journal uses ScholarOne Manuscripts (previously Manuscript Central) to peer review manuscript submissions. Please read the guide for ScholarOne authors before making a submission. Complete guidelines for preparing and submitting your manuscript to this journal are provided below.
该期刊使用 ScholarOne Manuscripts(前身为 Manuscript Central)对提交的稿件进行同行评审。在提交之前,请阅读 ScholarOne 作者指南。下面提供了准备和向本期刊提交稿件的完整指南。
Contents 内容
- About the Journal关于期刊
- Open Access 开放获取
- Peer Review and Ethics同行评议与伦理
- Preparing Your Paper准备论文
- Using Third-Party Material使用第三方材料
- Disclosure Statement 披露声明
- Clinical Trials Registry临床试验注册中心
- Ethics of Experimentation实验伦理
- Consent 同意
- Health and Safety健康与安全
- Submitting Your Paper提交论文
- Data Sharing Policy数据共享政策
- Publication Charges 出版费用
- Copyright Options 版权选项
- Complying with Funding Agencies遵守资助机构的规定
- My Authored Works我创作的作品
About the Journal 关于期刊
Transportmetrica B: Transport Dynamics is an international, peer-reviewed journal publishing high-quality, original research. Please see the journal's Aims & Scope for information about its focus and peer-review policy.
Transportmetrica B: Transport Dynamics是一本国际同行评审期刊,发表高质量的原创研究。请参阅该期刊的目标和范围,了解有关其重点和同行评审政策的信息。
Please note that this journal only publishes manuscripts in English.
请注意,本刊仅发表英文稿件。
Transportmetrica B: Transport Dynamics accepts the following types of article: original articles.
Transportmetrica B: Transport Dynamics接受以下类型的文章:原创文章。
Open Access 开放获取
You have the option to publish open access in this journal via our Open Select publishing program. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership and impact of your research. Articles published Open Select with Taylor & Francis typically receive 45% more citations* and over 6 times as many downloads** compared to those that are not published Open Select.
您可以选择通过我们的 Open Select 出版计划在本期刊上发表开放获取。开放获取意味着您的文章在发表后可以立即免费在线访问,从而提高您研究的知名度、读者群和影响力。与未发表的 Open Select 相比,与未发表的 Open Select 相比,与 Taylor & Francis 一起发表的文章通常获得 45% 的引用*和超过 6 倍的下载量**。
Your research funder or your institution may require you to publish your article open access. Visit our Author Services website to find out more about open access policies and how you can comply with these.
您的研究资助者或您的机构可能会要求您发表您的文章开放获取。请访问我们的作者服务网站,了解有关开放获取政策以及如何遵守这些政策的更多信息。
You will be asked to pay an article publishing charge (APC) to make your article open access and this cost can often be covered by your institution or funder. Use our APC finder to view the APC for this journal.
您将被要求支付文章出版费 (APC) 以使您的文章开放获取,这笔费用通常可以由您的机构或资助者承担。使用我们的 APC 查找器查看此期刊的 APC。
Please visit our Author Services website if you would like more information about our Open Select Program.
如果您想了解有关我们的开放选择计划的更多信息,请访问我们的作者服务网站。
*Citations received up to 9th June 2021 for articles published in 2018-2022. Data obtained on 23rd August 2023, from Digital Science's Dimensions platform, available at https://app.dimensions.ai **Usage in 2020-2022 for articles published in 2018-2022.
*截至 2021 年 6 月 9 日收到的 2018-2022 年发表的文章的引用。数据于 2023 年 8 月 23 日从 Digital Science 的 Dimensions 平台获得,可在 https://app.dimensions.ai **2018-2022 年发表的文章在 2020-2022 年的使用情况。
Peer Review and Ethics
同行评议与伦理
Taylor & Francis is committed to peer-review integrity and upholding the highest standards of review. Once your paper has been assessed for suitability by the editor, it will then be single anonymous peer reviewed by one independent, anonymous expert. If you have shared an earlier version of your Author’s Original Manuscript on a preprint server, please be aware that anonymity cannot be guaranteed. Further information on our preprints policy and citation requirements can be found on our Preprints Author Services page. Find out more about what to expect during peer review and read our guidance on publishing ethics.
Taylor & Francis致力于同行评审的完整性,并坚持最高的评审标准。一旦您的论文被编辑评估为合适性,它将由一位独立的匿名专家进行匿名同行评审。如果您在预印本服务器上分享了作者原始手稿的早期版本,请注意,无法保证匿名。有关我们的预印本政策和引文要求的更多信息,请访问我们的预印本作者服务页面。详细了解同行评审期间的预期,并阅读我们的出版道德指南。
Preparing Your Paper 准备论文
All authors submitting to medicine, biomedicine, health sciences, allied and public health journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).
所有向医学、生物医学、健康科学、相关和公共卫生期刊投稿的作者都应符合国际医学期刊编辑委员会 (ICMJE) 制定的《向生物医学期刊投稿的统一要求》。
Structure 结构
Your paper should be compiled in the following order: title page; abstract; keywords; main text introduction, materials and methods, results, discussion; acknowledgments; declaration of interest statement; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list).
您的论文应按以下顺序编译:标题页;抽象;关键字;正文介绍、材料与方法、结果、讨论;确认;利益申报表;引用;附录(视情况而定);带标题的表格(在单个页面上);数字;图标题(作为列表)。
Word Limits 字数限制
Please include a word count for your paper.
请为您的论文提供字数。
A typical paper for this journal should be no more than 10000 words
该期刊的典型论文不应超过 10000 字
Style Guidelines 风格指南
Please refer to these quick style guidelines when preparing your paper, rather than any published articles or a sample copy.
在准备论文时,请参考这些快速风格指南,而不是任何已发表的文章或样本副本。
Please use British (-ise) spelling style consistently throughout your manuscript.
请在整个稿件中始终使用英式 (-ise) 拼写风格。
Please use single quotation marks, except where ‘a quotation is “within” a quotation’.
请使用单引号,但“引号在引号内”的情况除外。
Please note that long quotations should be indented without quotation marks.
请注意,长引号应缩进,不带引号。
Formatting and Templates
格式和模板
Papers may be submitted in Word or LaTeX formats. Figures should be saved separately from the text. To assist you in preparing your paper, we provide formatting template(s).
论文可以以Word或LaTeX格式提交。图表应与正文分开保存。为了帮助您准备论文,我们提供了格式模板。
Word templates are available for this journal. Please save the template to your hard drive, ready for use.
本期刊提供 Word 模板。请将模板保存到您的硬盘上,以备使用。
A LaTeX template is available for this journal. Please save the LaTeX template to your hard drive and open it, ready for use, by clicking on the icon in Windows Explorer.
LaTeX模板可用于此期刊。请将 LaTeX 模板保存到您的硬盘驱动器,然后单击 Windows 资源管理器中的图标将其打开,以备使用。
If you are not able to use the template via the links (or if you have any other template queries) please contact us here.
如果您无法通过链接使用模板(或者您有任何其他模板查询),请在此处与我们联系。
References 引用
Please use this reference style when preparing your paper. An EndNote output style is also available to assist you.
在准备论文时,请使用这种参考样式。EndNote 输出样式也可用于为您提供帮助。
Taylor & Francis Editing Services
Taylor & Francis 编辑服务
To help you improve your manuscript and prepare it for submission, Taylor & Francis provides a range of editing services. Choose from options such as English Language Editing, which will ensure that your article is free of spelling and grammar errors, Translation, and Artwork Preparation. For more information, including pricing, visit this website.
为了帮助您改进稿件并准备投稿,Taylor & Francis提供了一系列编辑服务。从“英语语言编辑”等选项中进行选择,这将确保您的文章没有拼写和语法错误、翻译和插图准备。有关更多信息,包括定价,请访问此网站。
Checklist: What to Include
清单:包括什么
- Author details. Please ensure everyone meeting the International Committee of Medical Journal Editors (ICMJE) requirements for authorship is included as an author of your paper. Please ensure all listed authors meet the Taylor & Francis authorship criteria. All authors of a manuscript should include their full name and affiliation on the cover page of the manuscript. Where available, please also include ORCiDs and social media handles (Facebook, Twitter or LinkedIn). One author will need to be identified as the corresponding author, with their email address normally displayed in the article PDF (depending on the journal) and the online article. Authors’ affiliations are the affiliations where the research was conducted. If any of the named co-authors moves affiliation during the peer-review process, the new affiliation can be given as a footnote. Please note that no changes to affiliation can be made after your paper is accepted. Read more on authorship.
作者详细信息。请确保符合国际医学期刊编辑委员会 (ICMJE) 作者身份要求的每个人都被列为论文的作者。请确保所有列出的作者都符合泰勒和弗朗西斯的作者标准。稿件的所有作者都应在稿件的封面上注明其全名和单位。在可能的情况下,还请包括ORCiD和社交媒体句柄(Facebook,Twitter或LinkedIn)。需要将一位作者标识为通讯作者,其电子邮件地址通常显示在文章PDF(取决于期刊)和在线文章中。作者的隶属关系是进行研究的隶属关系。如果任何指定的合著者在同行评审过程中移动隶属关系,则可以将新的隶属关系作为脚注给出。请注意,您的论文被接受后,不能更改隶属关系。阅读更多关于作者身份的信息。 - Should contain an unstructured abstract of 150 words. Read tips on writing your abstract.
应包含 150 字的非结构化摘要。阅读撰写摘要的技巧。 - You can opt to include a video abstract with your article. Find out how these can help your work reach a wider audience, and what to think about when filming.
您可以选择在文章中包含视频摘要。了解这些如何帮助您的作品吸引更广泛的观众,以及拍摄时要考虑的事项。 - Between 3 and 6 keywords. Read making your article more discoverable, including information on choosing a title and search engine optimization.
介于 3 到 6 个关键字之间。阅读使您的文章更容易被发现,包括有关选择标题和搜索引擎优化的信息。 - Funding details. Please supply all details required by your funding and grant-awarding bodies as follows:
资金详情。请提供您的资助和赠款授予机构要求的所有详细信息,如下所示:
For single agency grants
对于单一机构赠款
This work was supported by the [Funding Agency] under Grant [number xxxx].
这项工作得到了 [资助机构] 在 Grant [number xxxx] 下的支持。
For multiple agency grants
对于多个机构赠款
This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number xxxx].
这项工作得到了 [资助机构 #1] 在 Grant [number xxxx] 下的支持;[资助机构 #2] 在赠款 [编号 xxxx];和 [资助机构 #3] 在 Grant [number xxxx ] 下。 - Disclosure statement. This is to acknowledge any financial or non-financial interest that has arisen from the direct applications of your research. If there are no relevant competing interests to declare please state this within the article, for example: The authors report there are no competing interests to declare. Further guidance on what is a conflict of interest and how to disclose it.
披露声明。这是为了承认因您的研究的直接应用而产生的任何财务或非财务利益。如果没有相关的竞争利益需要声明,请在文章中说明这一点,例如:作者报告说没有需要声明的竞争利益。关于什么是利益冲突以及如何披露利益冲突的进一步指导。 - Biographical note. Please supply a short biographical note for each author. This could be adapted from your departmental website or academic networking profile and should be relatively brief (e.g. no more than 200 words).
传记。请为每位作者提供简短的传记说明。这可以从您的部门网站或学术网络资料中改编,并且应该相对简短(例如不超过 200 字)。 - Data availability statement. If there is a data set associated with the paper, please provide information about where the data supporting the results or analyses presented in the paper can be found. Where applicable, this should include the hyperlink, DOI or other persistent identifier associated with the data set(s). Templates are also available to support authors.
数据可用性声明。如果有与论文相关的数据集,请提供资料,说明在何处可以找到支持论文中提出的结果或分析的数据。在适用的情况下,这应包括与数据集关联的超链接、DOI 或其他持久标识符。模板也可用于支持作者。 - Data deposition. If you choose to share or make the data underlying the study open, please deposit your data in a recognized data repository prior to or at the time of submission. You will be asked to provide the DOI, pre-reserved DOI, or other persistent identifier for the data set.
数据沉积。如果您选择共享或公开研究基础数据,请在提交之前或提交时将您的数据存放在公认的数据存储库中。您将被要求提供数据集的 DOI、预留 DOI 或其他永久标识符。 - Supplemental online material. Supplemental material can be a video, dataset, fileset, sound file or anything which supports (and is pertinent to) your paper. We publish supplemental material online via Figshare. Find out more about supplemental material and how to submit it with your article.
补充在线材料。补充材料可以是视频、数据集、文件集、声音文件或任何支持(并且与论文相关)的内容。我们通过Figshare在线发布补充材料。了解有关补充材料以及如何将其与文章一起提交的更多信息。 - Figures. Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour, at the correct size). Figures should be supplied in one of our preferred file formats: EPS, PS, JPEG, TIFF, or Microsoft Word (DOC or DOCX) files are acceptable for figures that have been drawn in Word. For information relating to other file types, please consult our Submission of electronic artwork document.
数字。图形应该是高质量的(线条艺术为 1200 dpi,灰度为 600 dpi,彩色为 300 dpi,尺寸正确)。图表应以我们首选的文件格式之一提供:EPS,PS,JPEG,TIFF或Microsoft Word(DOC或DOCX)文件对于在Word中绘制的图形是可接受的。有关其他文件类型的信息,请参阅我们的电子艺术品提交文件。 - Tables. Tables should present new information rather than duplicating what is in the text. Readers should be able to interpret the table without reference to the text. Please supply editable files.
表。表格应提供新的信息,而不是重复文本中的内容。读者应该能够在不参考文本的情况下解释表格。请提供可编辑的文件。 - Equations. If you are submitting your manuscript as a Word document, please ensure that equations are editable. More information about mathematical symbols and equations.
方程。如果您以 Word 文档的形式提交稿件,请确保方程式是可编辑的。有关数学符号和方程式的更多信息。 - Units. Please use SI units (non-italicized).
单位。请使用 SI 单位(非斜体)。
Using Third-Party Material
使用第三方材料
You must obtain the necessary permission to reuse third-party material in your article. The use of short extracts of text and some other types of material is usually permitted, on a limited basis, for the purposes of criticism and review without securing formal permission. If you wish to include any material in your paper for which you do not hold copyright, and which is not covered by this informal agreement, you will need to obtain written permission from the copyright owner prior to submission. More information on requesting permission to reproduce work(s) under copyright.
您必须获得必要的许可才能在文章中重复使用第三方材料。在未经正式许可的情况下,通常允许在有限的基础上为批评和审查目的使用简短的文本摘录和一些其他类型的材料。如果您希望在论文中包含任何您不拥有版权且未在本非正式协议涵盖范围内的材料,您需要在提交之前获得版权所有者的书面许可。有关请求复制受版权保护的作品的许可的更多信息。
Disclosure Statement 披露声明
Please include a disclosure statement, using the subheading “Disclosure of interest.” If you have no interests to declare, please state this (suggested wording: The authors report there are no competing interests to declare). For all NIH/Welcome-funded papers, the grant number(s) must be included in the declaration of interest statement. Read more on declaring conflicts of interest.
请附上一份披露声明,使用副标题“利益披露”。如果您没有利益需要申报,请说明这一点(建议措辞:作者报告没有需要申报的竞争利益)。对于所有 NIH/Welcome 资助的论文,资助编号必须包含在利益申报声明中。阅读更多关于声明利益冲突的信息。
Clinical Trials Registry
临床试验注册中心
In order to be published in a Taylor & Francis journal, all clinical trials must have been registered in a public repository, ideally at the beginning of the research process (prior to participant recruitment). Trial registration numbers should be included in the abstract, with full details in the methods section. Clinical trials should be registered prospectively – i.e. before participant recruitment. However, for clinical trials that have not been registered prospectively, Taylor & Francis journals requires retrospective registration to ensure the transparent and complete dissemination of all clinical trial results which ultimately impact human health. Authors of retrospectively registered trials must be prepared to provide further information to the journal editorial office if requested. The clinical trial registry should be publicly accessible (at no charge), open to all prospective registrants, and managed by a not-for-profit organization. For a list of registries that meet these requirements, please visit the WHO International Clinical Trials Registry Platform (ICTRP). The registration of all clinical trials facilitates the sharing of information among clinicians, researchers, and patients, enhances public confidence in research, and is in accordance with the ICMJE guidelines.
为了在Taylor & Francis期刊上发表,所有临床试验都必须在公共存储库中注册,最好是在研究过程开始时(在参与者招募之前)。试验注册号应包含在摘要中,详细信息应包含在方法部分。临床试验应前瞻性注册,即在招募受试者之前。然而,对于尚未前瞻性注册的临床试验,Taylor & Francis期刊要求进行回顾性注册,以确保透明和完整地传播所有最终影响人类健康的临床试验结果。回顾性注册试验的作者必须准备好在被要求时向期刊编辑部提供进一步的信息。临床试验注册库应向公众开放(免费),向所有潜在注册者开放,并由非营利组织管理。有关符合这些要求的注册库列表,请访问世卫组织国际临床试验注册平台(ICTRP)。所有临床试验的注册都有助于临床医生、研究人员和患者之间的信息共享,增强公众对研究的信心,并符合 ICMJE 指南。
Ethics of Experimentation
实验伦理
Please ensure that all research reported in submitted papers has been conducted in an ethical and responsible manner, and is in full compliance with all relevant codes of experimentation and legislation. All original research papers involving humans, animals, plants, biological material, protected or non-public datasets, collections or sites, must include a written statement in the Methods section, confirming ethical approval has been obtained from the appropriate local ethics committee or Institutional Review Board and that where relevant, informed consent has been obtained. For animal studies, approval must have been obtained from the local or institutional animal use and care committee. All research studies on humans (individuals, samples, or data) must have been performed in accordance with the principles stated in the Declaration of Helsinki. In settings where ethics approval for non-interventional studies (e.g. surveys) is not required, authors must include a statement to explain this. In settings where there are no ethics committees in place to provide ethical approval, authors are advised to contact the Editor to discuss further. Detailed guidance on ethics considerations and mandatory declarations can be found in our Editorial Policies section on Research Ethics.
请确保提交论文中报告的所有研究都是以合乎道德和负责任的方式进行的,并完全遵守所有相关的实验守则和立法。所有涉及人类、动物、植物、生物材料、受保护或非公开数据集、馆藏或站点的原始研究论文必须在“方法”部分包含书面声明,确认已获得适当的当地伦理委员会或机构审查委员会的伦理批准,并在相关情况下获得知情同意。对于动物研究,必须获得当地或机构动物使用和护理委员会的批准。所有关于人类(个人、样本或数据)的研究都必须按照《赫尔辛基宣言》中规定的原则进行。在不需要非干预性研究(例如调查)的伦理批准的情况下,作者必须附上一份声明来解释这一点。在没有伦理委员会提供伦理批准的情况下,建议作者联系编辑进一步讨论。有关伦理考虑和强制性声明的详细指南,请参阅我们关于研究伦理的编辑政策部分。
Consent 同意
All authors are required to follow the ICMJE requirements and Taylor & Francis Editorial Policies on privacy and informed consent from patients and study participants. Authors must include a statement to confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any type of qualitative or quantitative research, has given informed consent to participate in the research. For submissions where patients or participants can be potentially identified (e.g. a clinical case report detailing their medical history, identifiable images or media content, etc), authors must include a statement to confirm that they have obtained written informed consent to publish the details from the affected individual (or their parents/guardians if the participant in not an adult or unable to give informed consent; or next of kin if the participant is deceased). The process of obtaining consent to publish should include sharing the article with the individual (or whoever is consenting on their behalf), so that they are fully aware of the content of the article before it is published. Authors should familiarise themselves with our policy on participant/patient privacy and informed consent. They may also use the Consent to Publish Form, which can be downloaded from the same Author Services page.
所有作者都必须遵守ICMJE的要求和Taylor&Francis关于隐私和患者和研究参与者知情同意的编辑政策。作者必须包括一份声明,以确认任何类型的定性或定量研究中的任何患者、服务使用者或参与者(或该人的父母或法定监护人)已知情同意参与研究。对于可能识别患者或参与者的提交(例如,详细说明其病史的临床病例报告、可识别的图像或媒体内容等),作者必须附上一份声明,以确认他们已获得书面知情同意,以发布受影响个人的详细信息(如果参与者不是成年人或无法给予知情同意,则为其父母/监护人;如果参与者已故,则为近亲)。获得发布同意的过程应包括与个人(或代表他们同意的任何人)分享文章,以便他们在文章发布之前充分了解文章的内容。作者应熟悉我们关于参与者/患者隐私和知情同意的政策。他们也可以使用同意发布表格,该表格可以从同一作者服务页面下载。
Health and Safety 健康与安全
Please confirm that all mandatory laboratory health and safety procedures have been complied within the course of conducting any experimental work reported in your paper. Please ensure your paper contains all appropriate warnings on any hazards that may be involved in carrying out the experiments or procedures you have described, or that may be involved in instructions, materials, or formulae.
请确认在进行论文中报告的任何实验工作的过程中,已遵守所有强制性的实验室健康和安全程序。请确保您的论文包含所有适当的警告,说明在进行您描述的实验或程序时可能涉及的任何危险,或说明、材料或公式中可能涉及的任何危险。
Please include all relevant safety precautions; and cite any accepted standard or code of practice. Authors working in animal science may find it useful to consult the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare and Guidelines for the Treatment of Animals in Behavioural Research and Teaching. When a product has not yet been approved by an appropriate regulatory body for the use described in your paper, please specify this, or that the product is still investigational.
请包括所有相关的安全预防措施;并引用任何公认的标准或行为准则。从事动物科学工作的作者可能会发现,查阅国际兽医编辑协会的共识:《动物伦理和福利作者指南》和《行为研究和教学中动物治疗指南》很有用。当产品尚未获得适当的监管机构的批准用于您的论文中描述的用途时,请说明这一点,或者该产品仍处于研究阶段。
Submitting Your Paper 提交论文
This journal uses ScholarOne Manuscripts to manage the peer-review process. If you haven't submitted a paper to this journal before, you will need to create an account in ScholarOne. Please read the guidelines above and then submit your paper in the relevant Author Centre, where you will find user guides and a helpdesk.
该期刊使用 ScholarOne Manuscripts 来管理同行评审过程。如果您之前没有向本期刊投稿,则需要在ScholarOne中创建一个帐户。请阅读上述指南,然后在相关的作者中心提交您的论文,在那里您可以找到用户指南和服务台。
If you are submitting in LaTeX, please convert the files to PDF beforehand (you will also need to upload your LaTeX source files with the PDF).
如果您以 LaTeX 格式提交,请事先将文件转换为 PDF(您还需要将 LaTeX 源文件与 PDF 一起上传)。
Please note that Transportmetrica B: Transport Dynamics uses Crossref™ to screen papers for unoriginal material. By submitting your paper to Transportmetrica B: Transport Dynamics you are agreeing to originality checks during the peer-review and production processes.
请注意,Transportmetrica B: Transport Dynamics使用Crossref™来筛选论文中的非原创材料。通过将您的论文提交给Transportmetrica B: Transport Dynamics,您同意在同行评审和生产过程中进行原创性检查。
On acceptance, we recommend that you keep a copy of your Accepted Manuscript. Find out more about sharing your work.
在接受时,我们建议您保留一份已接受稿件的副本。详细了解如何分享您的作品。
Data Sharing Policy 数据共享政策
This journal applies the Taylor & Francis Basic Data Sharing Policy. Authors are encouraged to share or make open the data supporting the results or analyses presented in their paper where this does not violate the protection of human subjects or other valid privacy or security concerns.
本期刊采用Taylor & Francis基本数据共享政策。鼓励作者在不违反对人类受试者的保护或其他有效的隐私或安全问题的情况下,分享或公开支持其论文中呈现的结果或分析的数据。
Authors are encouraged to deposit the dataset(s) in a recognized data repository that can mint a persistent digital identifier, preferably a digital object identifier (DOI) and recognizes a long-term preservation plan. If you are uncertain about where to deposit your data, please see this information regarding repositories.
鼓励作者将数据集存放在公认的数据存储库中,该存储库可以铸造持久性数字标识符,最好是数字对象标识符 (DOI) 并识别长期保存计划。如果您不确定将数据存放在何处,请参阅有关存储库的信息。
Authors are further encouraged to cite any data sets referenced in the article and provide a Data Availability Statement.
进一步鼓励作者引用文章中引用的任何数据集,并提供数据可用性声明。
At the point of submission, you will be asked if there is a data set associated with the paper. If you reply yes, you will be asked to provide the DOI, pre-registered DOI, hyperlink, or other persistent identifier associated with the data set(s). If you have selected to provide a pre-registered DOI, please be prepared to share the reviewer URL associated with your data deposit, upon request by reviewers.
在提交时,系统会询问您是否有与论文相关的数据集。如果您回答“是”,您将被要求提供与数据集相关的 DOI、预注册 DOI、超链接或其他持久标识符。如果您选择提供预先注册的 DOI,请准备好根据审稿人的要求分享与您的数据存放关联的审稿人 URL。
Where one or multiple data sets are associated with a manuscript, these are not formally peer-reviewed as a part of the journal submission process. It is the author’s responsibility to ensure the soundness of data. Any errors in the data rest solely with the producers of the data set(s).
如果一个或多个数据集与稿件相关联,则这些数据集不会作为期刊提交过程的一部分进行正式的同行评审。确保数据的可靠性是作者的责任。数据中的任何错误完全由数据集的创建者负责。
Publication Charges 出版费用
There are no submission fees, publication fees or page charges for this journal.
本期刊不收取投稿费、出版费或版面费。
Color figures will be reproduced in color in your online article free of charge. If it is necessary for the figures to be reproduced in color in the print version, a charge will apply.
彩色数字将在您的在线文章中免费以彩色复制。如果需要在印刷版中以彩色复制数字,将收取费用。
Charges for color figures in print are £300 per figure ($400 US Dollars; $500 Australian Dollars; €350). For more than 4 color figures, figures 5 and above will be charged at £50 per figure ($75 US Dollars; $100 Australian Dollars; €65). Depending on your location, these charges may be subject to local taxes.
彩色印刷品的费用为每张300英镑(400美元;500澳元;350欧元)。对于超过 4 个彩色数字,数字 5 及以上将按每个数字 50 英镑(75 美元、100 澳元、65 欧元)收费。根据您所在的位置,这些费用可能需要缴纳当地税费。
Copyright Options 版权选项
Copyright allows you to protect your original material, and stop others from using your work without your permission. Taylor & Francis offers a number of different license and reuse options, including Creative Commons licenses when publishing open access. Read more on publishing agreements.
版权允许您保护您的原始材料,并阻止他人在未经您许可的情况下使用您的作品。Taylor & Francis 提供了许多不同的许可和重用选项,包括发布开放获取时的知识共享许可。阅读有关出版协议的更多信息。
Complying with Funding Agencies
遵守资助机构的规定
We will deposit all National Institutes of Health or Wellcome Trust-funded papers into PubMedCentral on behalf of authors, meeting the requirements of their respective open access policies. If this applies to you, please tell our production team when you receive your article proofs, so we can do this for you. Check funders’ open access policy mandates here. Find out more about sharing your work.
我们将代表作者将所有美国国立卫生研究院或惠康信托基金会资助的论文存入 PubMedCentral,以满足其各自开放获取政策的要求。如果这适用于您,请在收到文章校样时告诉我们的制作团队,以便我们为您完成。在此处查看资助者的开放获取政策要求。详细了解如何分享您的作品。
My Authored Works 我创作的作品
On publication, you will be able to view, download and check your article’s metrics (downloads, citations and Altmetric data) via My Authored Works on Taylor & Francis Online. This is where you can access every article you have published with us, as well as your free eprints link, so you can quickly and easily share your work with friends and colleagues.
发表后,您将能够通过Taylor & Francis Online上的My Authored Works查看,下载和检查文章的指标(下载,引用和Altmetric数据)。在这里,您可以访问您在我们这里发表的每篇文章,以及您的免费电子打印链接,以便您可以快速轻松地与朋友和同事分享您的作品。
We are committed to promoting and increasing the visibility of your article. Here are some tips and ideas on how you can work with us to promote your research.
我们致力于推广和提高您文章的知名度。这里有一些关于如何与我们合作以促进您的研究的提示和想法。
Queries 查询
If you have any queries, please visit our Author Services website or contact us here.
如果您有任何疑问,请访问我们的作者服务网站或在此处与我们联系。
Updated 6th June 2024
更新时间:2024 年 6 月 6 日
Sustainable and Smart Urban Mobility
可持续和智能的城市交通
The increasing demand for urban mobility has necessitated the use of various transport modes. Simply expanding road and railway infrastructure no longer suffices as a viable and sustainable solution to meet this demand. In such a context, developing innovative and environmentally friendly transport systems and services emerges as a promising alternative to catering to growing mobility demand while promoting sustainable urban development. This is accelerated by the rapid development in technology (e.g., autonomous vehicles, information and communication technologies) and the creation of new business models (e.g., shared mobility, mobility as a service, co-mobility). Both bring additional complexity and new dynamics to urban mobility, underpinning the growing number of research to explore advanced methodologies (e.g., artificial intelligence, machine learning). Nevertheless, substantial efforts are still required to harness state-of-the-art technology, exploit intelligent methodologies, advance analytical models, experiment with novel applications, etc., to achieve efficient, flexible, resilient, and cost-effective urban mobility.
对城市交通的需求不断增长,因此需要使用各种交通方式。仅仅扩大公路和铁路基础设施已不足以满足这一需求。在这样的背景下,发展创新和环保的交通系统和服务成为满足日益增长的交通需求同时促进可持续城市发展的有前途的替代方案。技术(如自动驾驶汽车、信息和通信技术)的快速发展和新商业模式(如共享出行、出行即服务、共出行)的快速发展加速了这一进程。两者都为城市交通带来了额外的复杂性和新的动态,支撑着越来越多的研究探索先进方法(例如,人工智能、机器学习)。然而,在利用最先进的技术、利用智能方法、推进分析模型、试验新应用等方面,仍需要付出大量努力,以实现高效、灵活、有弹性和具有成本效益的城市交通。
The purpose of this Special Issue of Transportmetrica B: Transport Dynamics is to publish high-quality and relevant research in all dynamic aspects of sustainable and smart urban mobility. We invite submissions that introduce new problems and concepts, develop innovative and rigorous methodologies, and provide novel insights into this emerging field of study. Papers may cover a range of topics including, but not limited to, the following:
本期《Transportmetrica B:Transport Dynamics》特刊旨在发表关于可持续和智能城市交通所有动态方面的高质量和相关研究。我们邀请提交引入新问题和新概念的投稿,开发创新和严谨的方法,并为这一新兴研究领域提供新的见解。论文可能涵盖一系列主题,包括但不限于以下内容:
- Emerging instruments for mobility demand management
用于移动需求管理的新兴工具 - Multimodal urban transport network capacity and resilience
多式联运城市交通网络容量和弹性 - Artificial intelligence/Machine learning methods for urban mobility
用于城市交通的人工智能/机器学习方法 - Environmental impact modelling and mitigating
环境影响建模和缓解 - Autonomous vehicles and unmanned aerial vehicle
自动驾驶汽车和无人机 - Real-time operation of the multimodal transport system
多式联运系统的实时运行 - Advances in multimodal assignment models
多模态分配模型的进展 - Complementarity and competition of multimodal transport
多式联运的互补性和竞争性 - Practices and policies for sustainable systems
可持续系统的实践和政策 - Shared mobility on public transit
公共交通的共享出行 - Taxi, paratransit, and public transit planning and operations
出租车、辅助交通和公共交通规划和运营 - Mobility-as-a-service 移动即服务
Paper submission deadline: 30 September, 2024
论文提交截止日期:2024年9月30日
Paper review and 1st revision: 31 December, 2024
论文评审和第一次修订:2024年12月31日
Paper review and 2nd revision: 28 February, 2025
论文审阅及二次修订:2025年2月28日
Final acceptance: 31 May, 2025
最终验收日期:2025年5月31日
Publication date (expected): 31 July, 2025
出版日期(预计):2025 年 7 月 31 日